Angelini Ventures-the Angelini Industries Group's corporate venture capital firm-takes on the role of co-lead in two strategic financing rounds, Neumirna Therapeutics and Nobi Smart Lights. These operations represent not only a confirmation of the company's ability to identify high-potential opportunities, but also testify its growth as an influential player in the industry.

Mental health is a fundamental pillar of individual and collective well-being, as well as an essential element in a country's socioeconomic growth. An effective system of prevention, diagnosis and treatment of mental illness not only improves the quality of life of citizens, but also contributes to the productivity and sustainability of the healthcare system and the labor market. The findings of the report "Mental Health as an Engine of Italy's Socioeconomic Growth", produced by Angelini Pharma in partnership with The European House - Ambrosetti highlight the importance of an integrated approach to addressing mental health challenges.

Written by Agnese Cattaneo, Chief Medical Officer, Angelini Pharma

Innovation plays a key role in the healthcare environment, an area in which Angelini Ventures, the venture capital firm of Angelini Industries, plays an active role by investing in and supporting cutting-edge startups in the biotechnology and digital health sectors. Angelini Ventures focuses its investments in five strategic segments: Biotech, TechBio, Connected Health Devices, Digital Diagnostics & Therapeutics, and Hybrid Care Platforms. The goal is to catalyze progress in crucial areas of health, starting with the understanding that curing means networking.

The transition from the concept of "new normal" to "polycrisis" has occurred in a surprisingly short span of time. This rapid transition highlights how global society has gone from adapting to a new post-pandemic status quo to dealing with a complexity of simultaneous and interconnected crises in record time. Faced with this scenario, the question arises: how can governments, organizations and individuals respond effectively to this "age of polycrisis"?